(Club de Revista 043) En el club de revista revisamos el reporte pos hoc del estudio fase III de Nintedanib para enfermedad pulmonar intersticial asociada a esclerosis sistémica. ENLACE: https://bit.ly/3bnOMRn
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
